Gene One Life Science postpones extraordinary shareholders meeting to Nov. 30

Bitget2026/10/14 07:30

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Gene One Life Science revised its shareholder-meeting call, pushing the extraordinary meeting to Nov. 30, 2026 from Oct. 30.
The voting record date shifted to Oct. 28, 2026 from Oct. 2.
Agenda scope expanded to include a proposed revision to executive retirement-benefit rules, alongside planned charter and board-related items.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gene One Life Science Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261014800361), on October 14, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Gene One Life Science postpones extraordinary shareholders meeting to Nov. 30

You may also like

Crypto prices

Gene One Life Science postpones extraordinary shareholders meeting to Nov. 30﻿

You may also like

Crypto prices

Gene One Life Science postpones extraordinary shareholders meeting to Nov. 30